Civic AI
Procurement intelligence
Federal contract award
DEVELOPMENT OF DIGITAL SATIORX, A VERY LOW COST REMOTELY CONTROLLABLE DISPOSABLE MICRONEEDLE TRANSDERMAL DRUG DELIVERY DEVICE ABLE TO DELIVER ANY LIQUID FDA APPROVED TRANSDERMAL DRUG
SATIO INC · Department of Health and Human Services
- Value
- $3,500,000
- Start
- Sep 30, 2023
- End
- Feb 3, 2026
- Action date
- Feb 3, 2026
- PIID
- 75N91023C00059
- Status
- completed
- NAICS
- 541715 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
- Place of performance
- BOSTON, MA
- Award type
- DEFINITIVE CONTRACT
Description
DEVELOPMENT OF DIGITAL SATIORX, A VERY LOW COST REMOTELY CONTROLLABLE DISPOSABLE MICRONEEDLE TRANSDERMAL DRUG DELIVERY DEVICE ABLE TO DELIVER ANY LIQUID FDA APPROVED TRANSDERMAL DRUG
Need modifications, related awards, and vendor peers? Open the full award workspace.